3 factors driving stock returns
Ultimately, these events shifted the outlooks for overall demand and supply, in turn having impacts on the three drivers of equity market returns: the profit outlook, interest rate outlook and risk premiums.
Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.
Ultimately, these events shifted the outlooks for overall demand and supply, in turn having impacts on the three drivers of equity market returns: the profit outlook, interest rate outlook and risk premiums.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.20% to 7206.90.
Balaji Gopal is the Head of Adviser Services at Vanguard Australia and one of the key people of the Vanguard organisation here in Australia.
The Resmed CDI (ASX: RMD) share price was crushed after its Q4 2023 financial results. Is Resmed’s share price an allergic reaction to Ozempic, or something else?
Following the Invocare takeover, the Propel Funeral Partners Ltd (ASX:PFP) share price could be ripe for the picking.
The Medibank Private Ltd (ASX:MPL) share price is in focus after reporting its FY23 result, which showed growth and revealed cyber costs.
The Sonic Healthcare Ltd (ASX:SHL) share price is down 5% after the business announced its FY23 result and gave FY24 guidance.
The Cochlear Limited (ASX: COH) share price bounced dramatically higher this week following a bumper report. But is the Cochlear share price looking a little expensive? Stock Doctor’s Daniel Ortisi weighs in.
The Pro Medicus Ltd (ASX:PME) share price has gained another 5% following the FY23 result which included more impressive growth.
Ultimately, these events shifted the outlooks for overall demand and supply, in turn having impacts on the three drivers of equity market returns: the profit outlook, interest rate outlook and risk premiums.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.20% to 7206.90.
Balaji Gopal is the Head of Adviser Services at Vanguard Australia and one of the key people of the Vanguard organisation here in Australia.
The Resmed CDI (ASX: RMD) share price was crushed after its Q4 2023 financial results. Is Resmed’s share price an allergic reaction to Ozempic, or something else?
Following the Invocare takeover, the Propel Funeral Partners Ltd (ASX:PFP) share price could be ripe for the picking.
The Medibank Private Ltd (ASX:MPL) share price is in focus after reporting its FY23 result, which showed growth and revealed cyber costs.
The Sonic Healthcare Ltd (ASX:SHL) share price is down 5% after the business announced its FY23 result and gave FY24 guidance.
The Cochlear Limited (ASX: COH) share price bounced dramatically higher this week following a bumper report. But is the Cochlear share price looking a little expensive? Stock Doctor’s Daniel Ortisi weighs in.
The Pro Medicus Ltd (ASX:PME) share price has gained another 5% following the FY23 result which included more impressive growth.
Want to level-up your analytical skills and investing insights but don’t know where to start? We can help. Join 40,000+ Australian investors on our mailing list today and we’ll send you our favourite podcasts, courses, resources, investment articles and podcasts every week. Delivered to your inbox every Sunday morning. Grab a coffee and let Owen and the team bring you the best investment insights every week.